The Importance of Nanocarrier Design and Composition for an Efficient Nanoparticle-Mediated Transdermal Vaccination

Overview

Journal Vaccines (Basel)

Date 2021 Dec 28

PMID 34960166

Citations 5

Authors

Rayen Yanara Valdivia-Olivares

Maria Rodriguez-Fernandez

Maria Javiera Alvarez-Figueroa

Alexis M Kalergis

Jose Vicente Gonzalez-Aramundiz

Affiliations

Soon will be listed here.

Abstract

The World Health Organization estimates that the pandemic caused by the SARS-CoV-2 virus claimed more than 3 million lives in 2020 alone. This situation has highlighted the importance of vaccination programs and the urgency of working on new technologies that allow an efficient, safe, and effective immunization. From this perspective, nanomedicine has provided novel tools for the design of the new generation of vaccines. Among the challenges of the new vaccine generations is the search for alternative routes of antigen delivery due to costs, risks, need for trained personnel, and low acceptance in the population associated with the parenteral route. Along these lines, transdermal immunization has been raised as a promising alternative for antigen delivery and vaccination based on a large absorption surface and an abundance of immune system cells. These features contribute to a high barrier capacity and high immunological efficiency for transdermal immunization. However, the stratum corneum barrier constitutes a significant challenge for generating new pharmaceutical forms for transdermal antigen delivery. This review addresses the biological bases for transdermal immunomodulation and the technological advances in the field of nanomedicine, from the passage of antigens facilitated by devices to cross the stratum corneum, to the design of nanosystems, with an emphasis on the importance of design and composition towards the new generation of needle-free nanometric transdermal systems.

Citing Articles

Next-Generation Vaccines: Nanovaccines in the Fight against SARS-CoV-2 Virus and beyond SARS-CoV-2.

Mufamadi M, Ngoepe M, Nobela O, Maluleke N, Phorah B, Methula B Biomed Res Int. 2023; 2023:4588659.

PMID: 37181817 PMC: 10175023. DOI: 10.1155/2023/4588659.

Poly(β-amino ester)s-Based Delivery Systems for Targeted Transdermal Vaccination.

Puigmal N, Ramos V, Artzi N, Borros S Pharmaceutics. 2023; 15(4).

PMID: 37111746 PMC: 10143071. DOI: 10.3390/pharmaceutics15041262.

Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems.

Nayak A, Warrier N, Kumar P Stem Cell Rev Rep. 2022; 18(7):2209-2233.

PMID: 35876959 PMC: 9489588. DOI: 10.1007/s12015-022-10426-9.

Beneath the Skin: A Review of Current Trends and Future Prospects of Transdermal Drug Delivery Systems.

Zaid Alkilani A, Nasereddin J, Hamed R, Nimrawi S, Hussein G, Abo-Zour H Pharmaceutics. 2022; 14(6).

PMID: 35745725 PMC: 9231212. DOI: 10.3390/pharmaceutics14061152.

Vaccines against Infectious Diseases and Cancer.

Sousa A, Soares C, Venuti A Vaccines (Basel). 2022; 10(5).

PMID: 35632404 PMC: 9144464. DOI: 10.3390/vaccines10050648.

References

Rai S, Pandey V, Rai G . Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art. Nano Rev Exp. 2018; 8(1):1325708. PMC: 6167026. DOI: 10.1080/20022727.2017.1325708. View

Toyoda M, Hama S, Ikeda Y, Nagasaki Y, Kogure K . Anti-cancer vaccination by transdermal delivery of antigen peptide-loaded nanogels via iontophoresis. Int J Pharm. 2015; 483(1-2):110-4. DOI: 10.1016/j.ijpharm.2015.02.024. View

He N, Warner K, Chantasart D, Shaker D, Higuchi W, Li S . Mechanistic study of chemical skin permeation enhancers with different polar and lipophilic functional groups. J Pharm Sci. 2004; 93(6):1415-30. DOI: 10.1002/jps.20030. View

Xia D, Jin R, Byagathvalli G, Yu H, Ye L, Lu C . An ultra-low-cost electroporator with microneedle electrodes (ePatch) for SARS-CoV-2 vaccination. Proc Natl Acad Sci U S A. 2021; 118(45). PMC: 8609327. DOI: 10.1073/pnas.2110817118. View

Zhang Y, Ng W, Feng X, Cao F, Xu H . Lipid vesicular nanocarrier: Quick encapsulation efficiency determination and transcutaneous application. Int J Pharm. 2016; 516(1-2):225-230. DOI: 10.1016/j.ijpharm.2016.11.011. View

Baroli B, Ennas M, Loffredo F, Isola M, Pinna R, Lopez-Quintela M . Penetration of metallic nanoparticles in human full-thickness skin. J Invest Dermatol. 2007; 127(7):1701-12. DOI: 10.1038/sj.jid.5700733. View

Du H, Wang Y, Haensel D, Lee B, Dai X, Nie Q . Multiscale modeling of layer formation in epidermis. PLoS Comput Biol. 2018; 14(2):e1006006. PMC: 5843350. DOI: 10.1371/journal.pcbi.1006006. View

Joyce J, Carroll T, Collins M, Chen M, Fritts L, Dutra J . A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques. J Infect Dis. 2018; 218(1):124-132. PMC: 5989599. DOI: 10.1093/infdis/jiy139. View

Cordeiro A, Alonso M, Fuente M . Nanoengineering of vaccines using natural polysaccharides. Biotechnol Adv. 2015; 33(6 Pt 3):1279-93. PMC: 7127432. DOI: 10.1016/j.biotechadv.2015.05.010. View

10.

Natsheh H, Touitou E . Phospholipid Vesicles for Dermal/Transdermal and Nasal Administration of Active Molecules: The Effect of Surfactants and Alcohols on the Fluidity of Their Lipid Bilayers and Penetration Enhancement Properties. Molecules. 2020; 25(13). PMC: 7412180. DOI: 10.3390/molecules25132959. View

11.

Yang L, Wu L, Wu D, Shi D, Wang T, Zhu X . Mechanism of transdermal permeation promotion of lipophilic drugs by ethosomes. Int J Nanomedicine. 2017; 12:3357-3364. PMC: 5413537. DOI: 10.2147/IJN.S134708. View

12.

Liu S, Jin M, Quan Y, Kamiyama F, Kusamori K, Katsumi H . Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin. Eur J Pharm Biopharm. 2013; 86(2):267-76. DOI: 10.1016/j.ejpb.2013.10.001. View

13.

Kolli C . Microneedles: bench to bedside. Ther Deliv. 2015; 6(9):1081-8. DOI: 10.4155/tde.15.67. View

14.

Oshio T, Komine M, Tsuda H, Tominaga S, Saito H, Nakae S . Nuclear expression of IL-33 in epidermal keratinocytes promotes wound healing in mice. J Dermatol Sci. 2016; 85(2):106-114. DOI: 10.1016/j.jdermsci.2016.10.008. View

15.

Pippa N, Gazouli M, Pispas S . Recent Advances and Future Perspectives in Polymer-Based Nanovaccines. Vaccines (Basel). 2021; 9(6). PMC: 8226647. DOI: 10.3390/vaccines9060558. View

16.

Yang J, Hu S, Zhao L, Kaplan D, Perdew G, Xiong N . Selective programming of CCR10(+) innate lymphoid cells in skin-draining lymph nodes for cutaneous homeostatic regulation. Nat Immunol. 2015; 17(1):48-56. PMC: 4838393. DOI: 10.1038/ni.3312. View

17.

Prausnitz M, Langer R . Transdermal drug delivery. Nat Biotechnol. 2008; 26(11):1261-8. PMC: 2700785. DOI: 10.1038/nbt.1504. View

18.

OShea J, Prausnitz M, Rouphael N . Dissolvable Microneedle Patches to Enable Increased Access to Vaccines against SARS-CoV-2 and Future Pandemic Outbreaks. Vaccines (Basel). 2021; 9(4). PMC: 8066809. DOI: 10.3390/vaccines9040320. View

19.

Banchereau J, Steinman R . Dendritic cells and the control of immunity. Nature. 1998; 392(6673):245-52. DOI: 10.1038/32588. View

20.

Gonzalez-Aramundiz J, Peleteiro Olmedo M, Gonzalez-Fernandez A, Alonso Fernandez M, Stefania Csaba N . Protamine-based nanoparticles as new antigen delivery systems. Eur J Pharm Biopharm. 2015; 97(Pt A):51-9. DOI: 10.1016/j.ejpb.2015.09.019. View